...
【24h】

A new internal target system for production of At-211 on the cyclotron U-120M

机译:一种新型内部靶系统,用于在回旋加速器U-120M上生产At-211

获取原文
获取原文并翻译 | 示例
           

摘要

The alpha emitter At-211 is a radionuclide with good potential for use in the therapy of smaller tumours and metastases. However, limited availability of this radionuclide hinders development of this application and the research of astatine chemistry in general. In this general context we have designed and tested a new internal target system. A thin bismuth layer (3-5 mu m) was evaporated onto a light target backing (7.5 g) and irradiated at 0.5-1.5 degrees angles with 29.5 MeV alpha particles beam of intensity up to 30 mu A. The backing was then released from the target holder and used directly for astatine separation via dry distillation. Astatine condensed on the Teflon capillary walls was then eluted into 150-250 mu l of methanol. The saturation yield was found to be ca. 400 MBq/mu A, and the radionuclidic purity of At-211 acceptable for medical applications (activity ratio At-210/At-211 < 10(-3) at EOB). The overall separation yield was 65-75%. (c) 2005 Elsevier Ltd. All rights reserved.
机译:α发射体At-211是一种放射性核素,具有潜力用于治疗较小的肿瘤和转移瘤。然而,这种放射性核素的有限可用性阻碍了该应用的发展以及总体上对a化学的研究。在这种一般情况下,我们设计并测试了一个新的内部目标系统。将薄的铋层(3-5微米)蒸发到轻质目标背衬(7.5克)上,并以0.5-1.5度角照射强度高达30微米的29.5 MeVα粒子束。然后从目标保持器,并通过干馏直接用于a分离。然后将在聚四氟乙烯毛细管壁上冷凝的洗脱到150-250μl甲醇中。发现饱和产率为约。 400 MBq / mu A,以及医学应用可接受的At-211的放射性核素纯度(EOB处的活度比At-210 / At-211 <10(-3))。总分离产率为65-75%。 (c)2005 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号